AGIO

Agios Pharmaceuticals Inc

Jun 23 • 04:00PM ET

35.59

+0.49 1.40 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: RYTM BMRN KRYS VKTX AXSM INCY KROS MDGL VRTX NBIX

| Held by: XBI VTI IWM VB VBK VXF IWN IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-7.25	Insider Own	6.36%	Shs Outstand	59.34M	Perf Week	11.85%
Market Cap	2.12B	Forward P/E	-	EPS next Y	-4.77	Insider Trans	-2.86%	Shs Float	55.69M	Perf Month	23.62%
Enterprise Value	1.42B	PEG	-	EPS next Q	-1.67	Inst Own	105.76%	Short Float	12.44%	Perf Quarter	26.61%
Income	-422.60M	P/S	32.05	EPS this Y	12.50%	Inst Trans	-2.06%	Short Ratio	6.07	Perf Half Y	43.91%
Sales	66.05M	P/B	1.90	EPS next Y	23.41%	ROA	-30.84%	Short Interest	6.93M	Perf YTD	30.75%
Book/sh	18.69	P/C	2.87	EPS next 5Y	21.45%	ROE	-32.82%	52W High	46.00 -22.63%	Perf Year	6.75%
Cash/sh	12.39	P/FCF	-	EPS past 3/5Y	-18.95% -8.46%	ROIC	-37.53%	52W Low	22.24 60.03%	Perf 3Y	32.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	55.97% -	Gross Margin	82.07%	Volatility	3.96% 4.98%	Perf 5Y	-36.91%
Dividend TTM	-	EV/Sales	21.43	EPS Y/Y TTM	-161.91%	Oper. Margin	-719.97%	ATR (14)	1.44	Perf 10Y	-26.62%
Dividend Ex-Date	-	Quick Ratio	13.59	Sales Y/Y TTM	78.34%	Profit Margin	-639.84%	RSI (14)	74.13	Recom	1.60
Dividend Gr. 3/5Y	- -	Current Ratio	14.19	EPS Q/Q	-8.50%	SMA20	18.58%	Beta	0.55	Target Price	40.75
Payout	-	Debt/Eq	0.03	Sales Q/Q	137.75%	SMA50	22.19%	Rel Volume	0.65	Prev Close	35.10
Employees	540	LT Debt/Eq	0.02	Earnings	Apr 29 BMO	SMA200	12.25%	Avg Volume	1.14M	Price	35.59
IPO	Jul 24, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.29% 55.98%	Trades		Volume	744,424	Change	1.40%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)